Van ECK Associates Corp acquired a new position in DocuSign, Inc. (NASDAQ:DOCU – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 51,858 shares of the company’s stock, valued at approximately $4,664,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Avior Wealth Management LLC raised its position in DocuSign by 36.5% in the 4th quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock worth $49,000 after purchasing an additional 145 shares during the period. Linden Thomas Advisory Services LLC raised its position in DocuSign by 1.1% in the 4th quarter. Linden Thomas Advisory Services LLC now owns 13,540 shares of the company’s stock worth $1,218,000 after purchasing an additional 149 shares during the period. J.W. Cole Advisors Inc. raised its position in DocuSign by 2.0% in the 3rd quarter. J.W. Cole Advisors Inc. now owns 7,946 shares of the company’s stock worth $493,000 after purchasing an additional 155 shares during the period. Optimist Retirement Group LLC raised its position in DocuSign by 3.8% in the 3rd quarter. Optimist Retirement Group LLC now owns 4,416 shares of the company’s stock worth $274,000 after purchasing an additional 161 shares during the period. Finally, Covestor Ltd raised its position in DocuSign by 5.8% in the 3rd quarter. Covestor Ltd now owns 3,306 shares of the company’s stock worth $205,000 after purchasing an additional 182 shares during the period. 77.64% of the stock is owned by hedge funds and other institutional investors.
DocuSign Price Performance
Shares of DOCU stock opened at $87.34 on Wednesday. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86. The stock’s 50-day moving average is $92.44 and its 200 day moving average is $75.87. The company has a market cap of $17.64 billion, a P/E ratio of 18.01, a PEG ratio of 7.56 and a beta of 0.89.
Insider Activity at DocuSign
Analyst Upgrades and Downgrades
A number of brokerages have recently commented on DOCU. UBS Group raised their target price on shares of DocuSign from $60.00 to $100.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. Morgan Stanley raised their target price on shares of DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a research report on Friday, December 6th. Citigroup raised their target price on shares of DocuSign from $87.00 to $113.00 and gave the stock a “buy” rating in a research report on Friday, December 6th. Jefferies Financial Group raised their target price on shares of DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Finally, Hsbc Global Res raised shares of DocuSign to a “moderate sell” rating in a research report on Friday, December 6th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, DocuSign currently has an average rating of “Hold” and a consensus target price of $92.45.
View Our Latest Stock Report on DocuSign
DocuSign Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Further Reading
- Five stocks we like better than DocuSign
- 3 Tickers Leading a Meme Stock Revival
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Market Cap Calculator: How to Calculate Market Cap
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Top Biotech Stocks: Exploring Innovation Opportunities
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.